Log in to save to my catalogue

Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer

Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_528aa4a3e7914e67822d83f66967eb8d

Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer

About this item

Full title

Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer

Publisher

London: Nature Publishing Group UK

Journal title

EMBO molecular medicine, 2021-05, Vol.13 (5), p.e13366-n/a

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Early relapse after platinum chemotherapy in epithelial ovarian cancer (EOC) portends poor survival.
A‐priori
identification of platinum resistance is therefore crucial to improve on standard first‐line carboplatin–paclitaxel treatment. The DNA repair pathway homologous recombination (HR) repairs platinum‐induced damage, and the HR recombinas...

Alternative Titles

Full title

Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_528aa4a3e7914e67822d83f66967eb8d

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_528aa4a3e7914e67822d83f66967eb8d

Other Identifiers

ISSN

1757-4676

E-ISSN

1757-4684

DOI

10.15252/emmm.202013366

How to access this item